Izzar Rachid
SEC CIK 1875506 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIIB | Biogen | Head of Gbl Product Strat | 11.8K | — | $300.1K | 30 | 2021-12-02 | 2026-02-06 |
Most active insiders at BIIB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Singhal Priya | Head of Development | — | $665.7K |
| 2 | Minor Lloyd | Dir | — | $239.7K |
| 3 | Murphy Nicole | Head of Pharm Ops, Tech | $585.12 | — |
| 4 | Godbout Sean | CAO | — | — |
| 5 | Pangalos Menelas N | Dir | — | — |
| 6 | Grogan Jane | Head of Research | — | — |
| 7 | LANGER SUSAN | Dir | — | — |
| 8 | Keeney Adam | Head of Corp. Development | — | — |
| 9 | Izzar Rachid | Head of Gbl Product Strat | — | — |
| 10 | Patolawala Monish D | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-10 | 2026-02-06 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +6,889 | 11.8K | +141% | $0 |
| DM | 2026-02-10 | 2026-02-06 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $201.18 | -2,038 | 11.0K | -16% | -$410.0K |
| 2025-07-16 | 2025-07-08 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | S - Sale | $135.00 | -2,223 | 6,330 | -26% | -$300.1K | |
| D | 2025-02-12 | 2025-02-10 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +1,515 | 8,998 | +20% | $0 |
| D | 2025-02-12 | 2025-02-10 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $142.54 | -445 | 8,553 | -5% | -$63.4K |
| DM | 2025-02-11 | 2025-02-07 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $141.35 | -1,165 | 6,059 | -16% | -$164.7K |
| DM | 2025-02-11 | 2025-02-07 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +3,844 | 7,224 | +114% | $0 |
| DM | 2024-02-21 | 2024-02-16 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $219.08 | -952 | 9,701 | -9% | -$208.6K |
| DM | 2024-02-21 | 2024-02-16 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +2,017 | 10.0K | +25% | $0 |
| D | 2024-02-13 | 2024-02-09 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $240.98 | -445 | 8,636 | -5% | -$107.2K |
| D | 2024-02-13 | 2024-02-09 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +1,515 | 9,081 | +20% | $0 |
| D | 2024-02-09 | 2024-02-08 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +2,043 | 8,187 | +33% | $0 |
| D | 2024-02-09 | 2024-02-08 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $240.30 | -621 | 7,566 | -8% | -$149.2K |
| D | 2023-07-05 | 2023-06-30 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +504 | 6,388 | +9% | $0 |
| D | 2023-07-05 | 2023-06-30 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $284.85 | -244 | 6,144 | -4% | -$69.5K |
| D | 2023-02-22 | 2023-02-17 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $278.38 | -371 | 5,117 | -7% | -$103.3K |
| D | 2023-02-22 | 2023-02-17 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +767 | 5,884 | +15% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +1,968 | 6,350 | +45% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Biogen | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $286.30 | -1,324 | 6,130 | -18% | -$379.1K |
| 2023-01-27 | 2023-01-25 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | A - Grant | $0.00 | +1,783 | 4,844 | +58% | $0 | |
| DM | 2022-12-06 | 2022-12-02 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +1,710 | 3,250 | +111% | $0 |
| DM | 2022-12-06 | 2022-12-02 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $298.90 | -759 | 3,061 | -20% | -$226.9K |
| D | 2022-07-06 | 2022-07-01 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $210.63 | -148 | 2,110 | -7% | -$31.2K |
| D | 2022-07-06 | 2022-07-01 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +504 | 2,258 | +29% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +594 | 1,929 | +44% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $209.79 | -175 | 1,754 | -9% | -$36.7K |
| D | 2022-02-15 | 2022-02-12 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $214.59 | -122 | 1,335 | -8% | -$26.2K |
| D | 2022-02-15 | 2022-02-12 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +351 | 1,457 | +32% | $0 |
| D | 2021-12-06 | 2021-12-02 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $228.52 | +372 | 1,271 | +41% | +$85.0K |
| D | 2021-12-06 | 2021-12-02 | BIIB | Biogen | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $228.52 | -165 | 1,106 | -13% | -$37.7K |
Purchase Sale Sale after option exercise All abbreviations